[go: up one dir, main page]

AUPR633101A0 - Method - Google Patents

Method

Info

Publication number
AUPR633101A0
AUPR633101A0 AUPR6331A AUPR633101A AUPR633101A0 AU PR633101 A0 AUPR633101 A0 AU PR633101A0 AU PR6331 A AUPR6331 A AU PR6331A AU PR633101 A AUPR633101 A AU PR633101A AU PR633101 A0 AUPR633101 A0 AU PR633101A0
Authority
AU
Australia
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR6331A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Priority to AUPR6331A priority Critical patent/AUPR633101A0/en
Publication of AUPR633101A0 publication Critical patent/AUPR633101A0/en
Priority to PCT/AU2002/000936 priority patent/WO2003006029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AUPR6331A 2001-07-13 2001-07-13 Method Abandoned AUPR633101A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR6331A AUPR633101A0 (en) 2001-07-13 2001-07-13 Method
PCT/AU2002/000936 WO2003006029A1 (en) 2001-07-13 2002-07-15 Method of inducing apoptosis in cancer cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6331A AUPR633101A0 (en) 2001-07-13 2001-07-13 Method

Publications (1)

Publication Number Publication Date
AUPR633101A0 true AUPR633101A0 (en) 2001-08-02

Family

ID=3830295

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR6331A Abandoned AUPR633101A0 (en) 2001-07-13 2001-07-13 Method

Country Status (2)

Country Link
AU (1) AUPR633101A0 (en)
WO (1) WO2003006029A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144221A1 (en) * 2001-07-17 2003-07-31 Isis Pharmaceuticals Inc. Antisense modulation of BCL2-associated X protein expression
CA2541015A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
KR101358810B1 (en) * 2011-12-30 2014-02-11 한국원자력의학원 IGFBP-5, a marker for diagnosing radiation exposure, a composition for diagnosing radiation exposure to measure the level of expression of the marker, a kit for diagnosing radiation exposure comprising the composition, and a method for diagnosing radiation exposure using the marker
CN106456694B (en) * 2013-12-20 2020-06-30 通用医疗公司 Methods and Assays Related to Circulating Tumor Cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546110B1 (en) * 1990-08-28 2001-11-14 Chiron Corporation New insulin-like growth factor binding protein igfbp-5
NZ516701A (en) * 1999-07-19 2004-11-26 Univ British Columbia Antisense therapy for hormone-regulated tumors

Also Published As

Publication number Publication date
WO2003006029A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
AU2002343483A1 (en) Hydroxypropylamines
AUPR454401A0 (en) Ladderlink
AU2002342918A1 (en) 2-guanidino-4-heterocyclylquinazolines
AU2002341150A1 (en) Method
AU2001237530A1 (en) Method
AU2002353397A1 (en) Mini-kraftformer
AU2001241636A1 (en) Halotherapy method
AU2002302604A1 (en) Process connection
AUPR633101A0 (en) Method
AU2002361985A1 (en) Microemulsifier
AU2002308561A1 (en) Selection method
AU2002228975A1 (en) Method
AU2001235770A1 (en) Method
AU2002313073A1 (en) Phytocystatin
AU2002249473A1 (en) Method
AU2002311155A1 (en) Dry-etcching method
AUPR858501A0 (en) Impregnational method
AU2002249345A1 (en) Method
AU2002251479A1 (en) Drawing method
AU2002304420A1 (en) Novel method
AU2002257925A1 (en) Numberplates
AU2002353664A1 (en) Routeplanner
AU2002242668A1 (en) Method for rock-chiseling
AUPR517901A0 (en) Selection method
AU2002251478A1 (en) Rendering method